These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12385012)

  • 21. Expansion of alpha-galactosylceramide-stimulated Valpha24+ NKT cells cultured in the absence of animal materials.
    Harada Y; Imataki O; Heike Y; Kawai H; Shimosaka A; Mori S; Kami M; Tanosaki R; Ikarashi Y; Iizuka A; Yoshida M; Wakasugi H; Saito S; Takaue Y; Takei M; Kakizoe T
    J Immunother; 2005; 28(4):314-21. PubMed ID: 16000949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dendritic cells are targets for human invariant Valpha24+ natural killer T-cell cytotoxic activity: an important immune regulatory function.
    Nicol A; Nieda M; Koezuka Y; Porcelli S; Suzuki K; Tadokoro K; Durrant S; Juji T
    Exp Hematol; 2000 Mar; 28(3):276-82. PubMed ID: 10720692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutting edge: analysis of human V alpha 24+CD8+ NK T cells activated by alpha-galactosylceramide-pulsed monocyte-derived dendritic cells.
    Takahashi T; Chiba S; Nieda M; Azuma T; Ishihara S; Shibata Y; Juji T; Hirai H
    J Immunol; 2002 Apr; 168(7):3140-4. PubMed ID: 11907064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CpG ODN enhance antigen-specific NKT cell activation via plasmacytoid dendritic cells.
    Marschner A; Rothenfusser S; Hornung V; Prell D; Krug A; Kerkmann M; Wellisch D; Poeck H; Greinacher A; Giese T; Endres S; Hartmann G
    Eur J Immunol; 2005 Aug; 35(8):2347-57. PubMed ID: 16025562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic activation of Valpha24+Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity.
    Nieda M; Okai M; Tazbirkova A; Lin H; Yamaura A; Ide K; Abraham R; Juji T; Macfarlane DJ; Nicol AJ
    Blood; 2004 Jan; 103(2):383-9. PubMed ID: 14512316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased expressions of CD1d molecule on liver dendritic cells in subcutaneous tumor bearing mice.
    Tatsumi T; Takehara T; Yamaguchi S; Sasakawa A; Yamamoto M; Fujita Y; Miyagi T; Ohkawa K; Hayashi N
    J Hepatol; 2008 Nov; 49(5):779-86. PubMed ID: 18760855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. H2-D(d)-mediated upregulation of interleukin-4 production by natural killer T-cell and dendritic cell interaction.
    Mizuuchi K; Yanagawa Y; Iwabuchi K; Namba K; Kitaichi N; Ohno S; Onoé K
    Immunology; 2008 May; 124(1):102-11. PubMed ID: 18194275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.
    Fujii S; Shimizu K; Kronenberg M; Steinman RM
    Nat Immunol; 2002 Sep; 3(9):867-74. PubMed ID: 12154358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of clinical and immunological effects of intravenous and intradermal administration of α-galactosylceramide (KRN7000)-pulsed dendritic cells.
    Nicol AJ; Tazbirkova A; Nieda M
    Clin Cancer Res; 2011 Aug; 17(15):5140-51. PubMed ID: 21653690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyporesponsiveness to natural killer T-cell ligand alpha-galactosylceramide in cancer-bearing state mediated by CD11b+ Gr-1+ cells producing nitric oxide.
    Yanagisawa K; Exley MA; Jiang X; Ohkochi N; Taniguchi M; Seino K
    Cancer Res; 2006 Dec; 66(23):11441-6. PubMed ID: 17145891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recovery of Valpha24+ NKT cells after hematopoietic stem cell transplantation.
    Haraguchi K; Takahashi T; Hiruma K; Kanda Y; Tanaka Y; Ogawa S; Chiba S; Miura O; Sakamaki H; Hirai H
    Bone Marrow Transplant; 2004 Oct; 34(7):595-602. PubMed ID: 15300228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination therapy of in vitro-expanded natural killer T cells and alpha-galactosylceramide-pulsed antigen-presenting cells in patients with recurrent head and neck carcinoma.
    Kunii N; Horiguchi S; Motohashi S; Yamamoto H; Ueno N; Yamamoto S; Sakurai D; Taniguchi M; Nakayama T; Okamoto Y
    Cancer Sci; 2009 Jun; 100(6):1092-8. PubMed ID: 19302288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients.
    Chang DH; Osman K; Connolly J; Kukreja A; Krasovsky J; Pack M; Hutchinson A; Geller M; Liu N; Annable R; Shay J; Kirchhoff K; Nishi N; Ando Y; Hayashi K; Hassoun H; Steinman RM; Dhodapkar MV
    J Exp Med; 2005 May; 201(9):1503-17. PubMed ID: 15867097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Valpha14 NKT cell-mediated anti-tumor responses and their clinical application.
    Seino K; Fujii S; Harada M; Motohashi S; Nakayama T; Fujisawa T; Taniguchi M
    Springer Semin Immunopathol; 2005 Jun; 27(1):65-74. PubMed ID: 15650847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient ex vivo expansion of Valpha24+ NKT cells derived from G-CSF-mobilized blood cells.
    Imataki O; Heike Y; Ishida T; Takaue Y; Ikarashi Y; Yoshida M; Wakasugi H; Kakizoe T
    J Immunother; 2006; 29(3):320-7. PubMed ID: 16699375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of human Valpha24(+)Vbeta11(+) NKT cells by age, malignancy and conventional anticancer therapies.
    Crough T; Purdie DM; Okai M; Maksoud A; Nieda M; Nicol AJ
    Br J Cancer; 2004 Nov; 91(11):1880-6. PubMed ID: 15520823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased intratumor Valpha24-positive natural killer T cells: a prognostic factor for primary colorectal carcinomas.
    Tachibana T; Onodera H; Tsuruyama T; Mori A; Nagayama S; Hiai H; Imamura M
    Clin Cancer Res; 2005 Oct; 11(20):7322-7. PubMed ID: 16243803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural killer T cell-mediated immunotherapy for malignant diseases.
    Motohashi S; Nakayama T
    Front Biosci (Schol Ed); 2009 Jun; 1(1):108-16. PubMed ID: 19482686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-21 enhances dendritic cell ability to induce interferon-gamma production by natural killer T cells.
    Maeda M; Yanagawa Y; Iwabuchi K; Minami K; Nakamaru Y; Takagi D; Fukuda S; Onoé K
    Immunobiology; 2007; 212(7):537-47. PubMed ID: 17678711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of alpha-galactosylceramide-activated Valpha14 natural killer T cells in the regulation of allergic diseases.
    Iwamura C; Nakayama T
    Allergol Int; 2007 Mar; 56(1):1-6. PubMed ID: 17259803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.